Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
33.30
+3.25 (10.83%)
At close: Oct 6, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $11.87 billion as of October 31, 2025. Its market cap has increased by 20.33% in one year.
Market Cap
11.87B
Enterprise Value
13.20B
Revenue
2.96B
Ranking
n/a
PE Ratio
8,606.93
Stock Price
$33.30
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 11.87B, an increase of 1,690.91%. That is a compound annual growth rate of 16.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 12.11B | 21.40% |
| Dec 30, 2024 | 9.98B | 9.75% |
| Dec 29, 2023 | 9.09B | 46.56% |
| Dec 30, 2022 | 6.20B | 1.41% |
| Dec 30, 2021 | 6.12B | 2.35% |
| Dec 30, 2020 | 5.98B | 22.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |